Latest Update By Google
-
Costs of UK-US Pharma Deal will be met by DHSC, Science Minister confirms - Committees
February 4th 2026 12:05AM
The Science Minister, Lord Patrick Vallance, has provided further details of the recently announced ...
-
Mankind Pharma Revenue Jumps 11.5% Post-BSV Acquisition, But Margins Squeeze
February 3rd 2026 11:22PM
Mankind Pharma reported Q3 FY26 revenue growth of 11.5% YoY to ₹3567 Cr, buoyed by the significant...
-
LSL PHARMA GROUP GRANTS STOCK OPTIONS - Yahoo Finance
February 3rd 2026 9:58PM
LSL PHARMA GROUP INC. (TSXV: LSL) (The "Corporation" or "LSL Pharma"), a Canadia...
-
Pharma companies await clarity, eye a dose of stability in India-US deal
February 3rd 2026 8:48PM
... pharmaceutical market. While the sector was insulated from punitive US tariffs, the generics bus...
-
Strides Pharma Q3 FY26 revenue rises 3.6% to ₹1194 cr, PAT at ₹128 cr
February 3rd 2026 8:26PM
Strides Pharma has announced a 3.6% increase in revenue to ₹1194 crore for Q3 FY 2025-26, with a n...
-
Sun Pharma Advanced Research secures Sezaby's priority review voucher from FDA
February 3rd 2026 8:21PM
Sun Pharma Advanced Research Company announced the FDA granted a Priority Review Voucher for Sezaby,...
-
Rs 10,000 crore worth of MoUs agreed upon at UP Pharma Conclave
February 3rd 2026 8:06PM
Uniindia: Lucknow, Feb 3 (UNI) Memorandums of Understanding (MoUs) related to investments exceeding ...
-
EQL Pharma Interim Report April – December 2025
February 3rd 2026 7:33PM
The third quarter of 2025/26 marks a recovery for EQL Pharma. Sales growth of 29 percent and EBITDA ...
-
Natco Pharma Gets USFDA Tentative Approval for Cancer Drug Erdafitinib
February 3rd 2026 7:04PM
Hyderabad: Natco Pharma Limited has received tentative approval from the United States Food and Drug...
-
Natco Pharma gets U.S. FDA tentative nod for generic of Janssen's cancer drug - The Hindu
February 3rd 2026 6:58PM
Natco Pharma has received U.S. Food and Drug Administration's tentative approval for Erdafitinib...
-
MFs' Bets: 15 smallcap stocks turn volatile, tumble up to 50% in 3 months. Do you own any?
February 3rd 2026 6:50PM
Onesource Specialty Pharma. ... Mutual fund holdings rose to 12.20% from 11.94%. Onesource Specialty...
-
India-US trade deal promises policy clarity, fuels Indian pharma's US growth
February 3rd 2026 5:56PM
"Pharma generics was hitherto left outside the tariffs. The FTA now provides clarity on that. T...
-
734% Profit Growth: Pharma Stock hits 10% upper circuit after announcing strong Q3 results
February 3rd 2026 5:14PM
This Pharma Stock, engaged in manufacturing active pharmaceutical ingredients (APIs), bulk drugs, in...
-
India-US trade deal game-changer for MedTech, pharma sectors: Industry - tennews.in
February 3rd 2026 5:04PM
New Delhi, Feb 3 (IANS) The trade deal between India and the US is a game-changer for the Indian Med...
-
MoUs worth Rs 10000 crore inked at UP Pharma Conclave
February 3rd 2026 4:52PM
During the conclave, which was inaugurated by Chief Minister Yogi Adityanath, major investors includ...
-
aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod ...
February 3rd 2026 4:37PM
03, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a c...
-
Mapi Pharma to Present New Safety and Efficacy Data from Glatiramer Acetate Depot Long ...
February 3rd 2026 4:05PM
NESS ZIONA, Israel, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-sta...
-
CM Yogi Adityanath inaugurates 'Uttar Pradesh Pharma Conclave 1.0' in Lucknow
February 3rd 2026 4:04PM
'Lalitpur Bulk Drug Pharma Park' being developed on a hub-and-spoke model. Chief Minister (C...
-
Natco Pharma gets USFDA nod for cancer generic drug - The HinduBusinessLine
February 3rd 2026 3:42PM
Natco Pharma receives USFDA approval for Erdafitinib, a generic cancer drug for advanced urothelial ...
-
Pharma stocks slump as Pfizer and Merck report earnings - Yahoo Finance
February 3rd 2026 3:27PM
The pharma industry is handling big transitions. New earnings give a good read on the sector and the...